zalcitabine has been researched along with dideoxyadenosine in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (51.43) | 18.7374 |
| 1990's | 11 (31.43) | 18.2507 |
| 2000's | 3 (8.57) | 29.6817 |
| 2010's | 1 (2.86) | 24.3611 |
| 2020's | 2 (5.71) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Bentrude, WG; De Clercq, E; Mullah, KB; Rao, TS | 1 |
| Baba, M; Hayakawa, H; Miyasaka, T; Nitta, I; Sakamaki, T; Sekiya, K; Shigeta, S; Takashima, H; Tanaka, H; Ubasawa, M | 1 |
| Corbett, TH; Court, BA; Kessel, D; Phadtare, S; Renis, HE; Zimlicka, J | 1 |
| Aoki, S; Barchi, JJ; Driscoll, JS; Ford, H; Kelley, JA; Marquez, VE; Mitsuya, H; Shirasaka, T | 1 |
| Baba, M; Balzarini, J; De Clercq, E; Hayakawa, H; Miyasaka, T; Tanaka, H; Walker, RT | 1 |
| Broder, S; Driscoll, JS; Kim, CH; Marquez, VE; Mitsuya, H | 1 |
| Baba, M; Balzarini, J; Broder, S; De Clercq, E; Herdewijn, P; Pauwels, R; Vanderhaeghe, H | 1 |
| Antonenko, SV; Chentsova, NP; Kukhar, VP; Luik, AI; Poda, GI; Tetko, IV | 1 |
| Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC | 1 |
| Aubertin, AM; Périgaud, C; Peyrottes, S; Villard, AL | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chattopadhyaya, J; Koole, LH; Plavec, J | 1 |
| Cao, W; Fuchs, BA; Germolec, DR; Luster, MI; Munson, AE; Prejean, JD; Rosenthal, GJ; Shopp, G; Thompson, MB; Tomaszewski, JE | 1 |
| Broder, S; DeVico, AL; Di Marzo Veronese, F; Jarrett, RF; Johns, DG; Matsukura, M; Mitsuya, H; Reitz, MS; Sarngadharan, MG | 1 |
| Benveniste, RE; Follis, KE; Tsai, CC | 1 |
| Chisaka, O; Matsubara, K; Nagahata, T; Tsurimoto, T; Ueda, K | 1 |
| Ganser, A; Greher, J; Hoelzer, D; Staszewski, S; Völkers, B | 1 |
| de Noronha, F; Postie, L; Roneker, C; Tavares, L | 1 |
| Blair, PC; Fort, MM; Fuchs, BA; Germolec, DR; Luster, MI; McCay, JA; Munson, AE; Thompson, M; Tomaszewski, JE; White, KL | 1 |
| Plagemann, PG; Woffendin, C | 1 |
| Carson, DA; Kornbluth, RS; Richman, DD | 1 |
| Fridland, A; Johns, DG; Johnson, MA | 1 |
| Broder, S; Mitsuya, H | 2 |
| Pardridge, WM; Terasaki, T | 1 |
| Cooney, DA; Gartner, S; Gerrard, TL; Hao, Z; Hartman, NR; Johns, DG; Perno, CF; Popovic, M; Wilson, YA; Yarchoan, R | 1 |
| Hill, DL; Kalin, JR | 1 |
| Haugwitz, RD; Quinn, FR; Silverton, JV; Torado, LJ | 1 |
| Kitos, TE; Tyrrell, DL | 1 |
| Balzarini, J | 1 |
| Howe, AY; Robins, MJ; Tyrrell, DL; Wilson, JS | 1 |
| Davies, RJ; Starrs, S | 1 |
| Knecht, W; Munch-Petersen, B; Piskur, J | 1 |
| Dickman, K; Lake-Bakaar, G; Lyubsky, S; Mazzoccoli, V | 1 |
| Asif, G; Coats, SJ; Detorio, M; Koontz, D; Mellors, JW; Meteer, JD; Schinazi, RF; Sluis-Cremer, N; Solomon, S; Zhang, HW | 1 |
1 review(s) available for zalcitabine and dideoxyadenosine
| Article | Year |
|---|---|
Metabolism and mechanism of antiretroviral action of purine and pyrimidine derivatives.
Topics: Animals; Antiviral Agents; Dideoxyadenosine; Dideoxynucleosides; Humans; Lamivudine; Purines; Pyrimidines; Retroviridae; Spiro Compounds; Stavudine; Thymidine; Uridine; Zalcitabine; Zidovudine | 1994 |
34 other study(ies) available for zalcitabine and dideoxyadenosine
| Article | Year |
|---|---|
Potential prodrug derivatives of 2',3'-didehydro-2',3'-dideoxynucleosides. Preparations and antiviral activities.
Topics: Antiviral Agents; Cytopathogenic Effect, Viral; Dideoxyadenosine; Dideoxynucleosides; HIV-1; Humans; Microbial Sensitivity Tests; Prodrugs; Tumor Cells, Cultured; Virus Replication; Viruses | 1992 |
A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti-HIV-1 activity of 5- or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT).
Topics: Antiviral Agents; Cell Line; Cell Survival; HIV-1; Humans; Indicators and Reagents; Molecular Structure; Structure-Activity Relationship; Thymine | 1991 |
Unsaturated and carbocyclic nucleoside analogues: synthesis, antitumor, and antiviral activity.
Topics: Adenosine Deaminase; Animals; Antimetabolites, Antineoplastic; Antiviral Agents; Cell Line; Cell Survival; Drug Screening Assays, Antitumor; Friend murine leukemia virus; HIV-1; HIV-2; Humans; Indicators and Reagents; Leukemia L1210; Mice; Molecular Structure; Nucleosides; Rauscher Virus; Structure-Activity Relationship | 1991 |
Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs.
Topics: Adenosine Deaminase; Antiviral Agents; Cells, Cultured; Chemical Phenomena; Chemistry; Chromatography, High Pressure Liquid; Dideoxynucleosides; HIV; Kinetics; Prodrugs; Structure-Activity Relationship | 1991 |
A novel lead for specific anti-HIV-1 agents: 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Topics: Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Chemical Phenomena; Chemistry; HIV-1; HIV-2; Mice; Molecular Conformation; Reverse Transcriptase Inhibitors; Thymine; Virus Replication | 1989 |
Potential anti-AIDS drugs. 2',3'-Dideoxycytidine analogues.
Topics: Acquired Immunodeficiency Syndrome; Cell Line; Chemical Phenomena; Chemistry; Deoxycytidine; HIV; Structure-Activity Relationship; T-Lymphocytes, Helper-Inducer; Zalcitabine | 1987 |
3'-substituted 2',3'-dideoxynucleoside analogues as potential anti-HIV (HTLV-III/LAV) agents.
Topics: Antiviral Agents; Cell Line; Chemical Phenomena; Chemistry; Cytopathogenic Effect, Viral; Deoxyribonucleosides; HIV; Humans; Structure-Activity Relationship; T-Lymphocytes; Virus Replication | 1987 |
HIV-1 reverse transcriptase inhibitor design using artificial neural networks.
Topics: Algorithms; Cell Line; Drug Design; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Neural Networks, Computer; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; T-Lymphocytes; Zidovudine | 1994 |
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine | 2007 |
An original pronucleotide strategy for the simultaneous delivery of two bioactive drugs.
Topics: Anti-HIV Agents; Antiviral Agents; Cell Line, Tumor; Cell Survival; Drug Carriers; HIV-1; Humans; Nucleotides; Prodrugs | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Structural analysis of 2',3'-dideoxyinosine, 2',3'-dideoxyadenosine, 2',3'-dideoxyguanosine and 2',3'-dideoxycytidine by 500-MHz 1H-NMR spectroscopy and ab-initio molecular orbital calculations.
Topics: Didanosine; Dideoxyadenosine; Dideoxynucleosides; Magnetic Resonance Spectroscopy; Models, Chemical; Molecular Structure; Spectrum Analysis; Structure-Activity Relationship; Temperature; Thermodynamics; Zalcitabine | 1992 |
Experimental studies of the hematologic and immune system toxicity of nucleoside derivatives used against HIV infection.
Topics: Animals; Bone Marrow; Didanosine; Dideoxyadenosine; Female; HIV Infections; Immune System; Immunoglobulin M; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Zalcitabine; Zidovudine | 1991 |
Long-term inhibition of human T-lymphotropic virus type III/lymphadenopathy-associated virus (human immunodeficiency virus) DNA synthesis and RNA expression in T cells protected by 2',3'-dideoxynucleosides in vitro.
Topics: Antiviral Agents; Base Sequence; Cell Line; Deoxyadenosines; Deoxycytidine; Dideoxyadenosine; DNA Replication; HIV; Humans; RNA-Directed DNA Polymerase; RNA, Messenger; T-Lymphocytes; Transcription, Genetic; Zalcitabine | 1987 |
Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
Topics: Animals; Antiviral Agents; Cell Line; Cytopathogenic Effect, Viral; Dideoxyadenosine; Dideoxynucleosides; Humans; Macaca mulatta; Microbial Sensitivity Tests; Reverse Transcriptase Inhibitors; Simian Immunodeficiency Virus; Zalcitabine; Zidovudine | 1988 |
An in vitro system for screening anti-hepatitis B virus drugs.
Topics: Acyclovir; Adenine; Antiviral Agents; Blotting, Southern; Carcinoma, Hepatocellular; Cytarabine; Dideoxyadenosine; Dideoxynucleosides; DNA Replication; DNA, Viral; Hepatitis B virus; Humans; Interferons; Liver Neoplasms; Tumor Cells, Cultured; Vidarabine; Virus Replication; Zalcitabine; Zidovudine | 1989 |
Inhibitory effect of azidothymidine, 2'-3'-dideoxyadenosine, and 2'-3'-dideoxycytidine on in vitro growth of hematopoietic progenitor cells from normal persons and from patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Complex; Bone Marrow; Colony-Forming Units Assay; Deoxyribonucleosides; Dideoxyadenosine; Dideoxynucleosides; Dose-Response Relationship, Drug; Growth Inhibitors; Hematopoiesis; Hematopoietic Stem Cells; Humans; Zalcitabine; Zidovudine | 1989 |
Testing of nucleoside analogues in cats infected with feline leukemia virus: a model.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antibodies, Viral; Antiviral Agents; Cats; Cell Line; Didanosine; Dideoxyadenosine; Dideoxynucleosides; Disease Models, Animal; Drug Evaluation, Preclinical; Immunologic Deficiency Syndromes; Leukemia Virus, Feline; Leukemia, Experimental; Nucleosides; Specific Pathogen-Free Organisms; Virus Replication; Zalcitabine; Zidovudine | 1989 |
A comparison of three nucleoside analogs with anti-retroviral activity on immune and hematopoietic functions in mice: in vitro toxicity to precursor cells and microstromal environment.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antigen-Antibody Reactions; Antiviral Agents; Bone Marrow; Dideoxyadenosine; Female; Hematopoiesis; HIV; Immunity, Cellular; Macrophages; Mice; Mice, Inbred C57BL; Spleen; Stem Cells; T-Lymphocytes; Virus Replication; Zalcitabine; Zidovudine | 1989 |
Permeation and salvage of dideoxyadenosine in mammalian cells.
Topics: Animals; Carrier Proteins; Coformycin; Deamination; Dideoxyadenosine; Dideoxynucleosides; Erythrocytes; Humans; Leukemia, Experimental; Membrane Proteins; Mice; Nucleoside Transport Proteins; Pentostatin; Permeability; Zalcitabine | 1989 |
Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
Topics: Adenosine Kinase; Cell Line; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dideoxyadenosine; HIV; Humans; Macrophages; Phosphorylation; T-Lymphocytes; Thymidine; Thymidine Kinase; Uridine Kinase; Virus Replication; Zalcitabine; Zidovudine | 1987 |
2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
Topics: Acquired Immunodeficiency Syndrome; Coformycin; Deoxyadenosines; Deoxycytidine; Deoxycytidine Kinase; Dideoxyadenosine; Humans; Kinetics; Pentostatin; Phosphorylation; Phosphotransferases; Structure-Activity Relationship; Thymus Extracts; Thymus Gland; Zalcitabine | 1987 |
Inhibition of infectivity and replication of HIV-2 and SIV in helper T-cells by 2',3'-dideoxynucleosides in vitro.
Topics: Cytopathogenic Effect, Viral; Deoxyadenosines; Deoxycytidine; Dideoxyadenosine; HIV; In Vitro Techniques; Nucleosides; Retroviridae; T-Lymphocytes, Helper-Inducer; Thymidine; Viral Proteins; Virus Replication; Zalcitabine; Zidovudine | 1988 |
Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier.
Topics: Animals; Antiviral Agents; Blood-Brain Barrier; Deoxyadenosines; Deoxycytidine; Dideoxyadenosine; Liver; Male; Rats; Rats, Inbred Strains; Thymidine; Zalcitabine; Zidovudine | 1988 |
Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.
Topics: Antiviral Agents; Deoxycytidine Kinase; Dideoxyadenosine; Dideoxynucleosides; HIV; Humans; In Vitro Techniques; Macrophages; Monocytes; Phosphorylation; Thymidine Kinase; Time Factors; Virus Replication; Zalcitabine; Zidovudine | 1988 |
Determination of 2',3'-dideoxyadenosine, 2',3'-dideoxyinosine and 2',3'-dideoxycytidine in biological samples.
Topics: Animals; Antiviral Agents; Cats; Chromatography, High Pressure Liquid; Chromatography, Ion Exchange; Didanosine; Dideoxyadenosine; Dideoxynucleosides; Female; Half-Life; Injections, Intravenous; Mice; Mice, Inbred Strains; Rats; Rats, Inbred F344; Spectrophotometry, Ultraviolet; Zalcitabine | 1988 |
Structures of two dideoxynucleosides: 2',3'-dideoxyadenosine and 2',3'-dideoxycytidine.
Topics: Crystallography; Dideoxyadenosine; Hydrogen Bonding; Molecular Conformation; Molecular Structure; X-Ray Diffraction; Zalcitabine | 1988 |
Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
Topics: Antiviral Agents; Carbohydrate Conformation; Cell Division; Cytopathogenic Effect, Viral; Deltaretrovirus; Deoxyadenosines; Deoxycytidine; Deoxyribonucleosides; Dideoxyadenosine; Dideoxynucleosides; Gene Products, gag; Humans; Lymphocyte Activation; Mitogens; Retroviridae Proteins; Structure-Activity Relationship; T-Lymphocytes; Thymidine; Vidarabine; Zalcitabine | 1986 |
Intracellular metabolism of 2',3'-dideoxynucleosides in duck hepatocyte primary cultures.
Topics: Animals; Animals, Newborn; Antiviral Agents; Cells, Cultured; Deoxycytidine; Dideoxyadenosine; Dideoxynucleosides; Ducks; Hepatitis B Virus, Duck; Liver; Phosphorylation; Zalcitabine | 1995 |
Selective inhibition of the reverse transcription of duck hepatitis B virus by binding of 2',3'-dideoxyguanosine 5'-triphosphate to the viral polymerase.
Topics: Animals; Antiviral Agents; Blotting, Northern; Blotting, Southern; Deoxyguanine Nucleotides; Depression, Chemical; Dideoxyadenosine; Dideoxynucleotides; DNA-Directed DNA Polymerase; Ducks; Hepatitis B Virus, Duck; RNA-Directed DNA Polymerase; Transcription, Genetic; Virus Replication; Zalcitabine | 1996 |
Prevention of anomalous band mobility in A + G sequencing ladders of 3'-end-labeled DNA.
Topics: Dideoxyadenosine; DNA; Electrophoresis, Polyacrylamide Gel; Hydrogen-Ion Concentration; Kinetics; Phosphorus Radioisotopes; Sequence Analysis, DNA; Zalcitabine | 1999 |
Identification of residues involved in the specificity and regulation of the highly efficient multisubstrate deoxyribonucleoside kinase from Drosophila melanogaster.
Topics: Animals; Cytarabine; Dideoxyadenosine; Directed Molecular Evolution; Drosophila melanogaster; Enzyme Activation; Feedback; Inhibitory Concentration 50; Kinetics; Mutation; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Polymerase Chain Reaction; Substrate Specificity; Thymidine; Thymine Nucleotides; Zalcitabine; Zidovudine | 2000 |
Differential effects of nucleoside analogs on oxidative phosphorylation in human pancreatic cells.
Topics: Antimetabolites; Cells, Cultured; Didanosine; Dideoxyadenosine; DNA, Mitochondrial; Humans; Oxidative Phosphorylation; Pancreas; Zalcitabine | 2001 |
The base component of 3'-azido-2',3'-dideoxynucleosides influences resistance mutations selected in HIV-1 reverse transcriptase.
Topics: Anti-HIV Agents; Azides; Base Sequence; Dideoxyadenosine; Dideoxynucleosides; Drug Resistance, Viral; HIV Reverse Transcriptase; HIV-1; Mutagenesis, Site-Directed; Reverse Transcriptase Inhibitors; Sequence Analysis, RNA; Zalcitabine; Zidovudine | 2011 |